RESEARCH: CANCER
FOLDING PROJECT #16934 PROFILE

This project relates to understanding how small proteins fold and how changes to their design affect how well they stick to other molecules. This knowledge could help create better cancer drugs.

Note: This TLDR is a simplication and may not be 100% accurate.

These simulations are designed to test our understanding the folding mechanism of alpha-helical hairpins.

We are trying to study how disulfide cross-linkers and sequence variants affect the folding thermodynamics and kinetics of these proteins, to learn how we might better use molecular simulation methods to design effective protein binder scaffolds, for use as "affibody" cancer therapeutics, for example.

---

alpha-helical hairpins

Secondary structure of proteins characterized by alpha-helices forming hairpin shapes.

Alpha-helical hairpins are a common structural motif in proteins. They consist of two alpha-helices connected by a short loop. These structures are important for protein folding and function. Studying how these hairpins fold can help us understand how proteins work and design new drugs.

---

disulfide cross-linkers

Covalent bonds between cysteine residues in proteins that stabilize protein structure.

Disulfide cross-linkers are strong chemical bonds formed between two sulfur atoms from cysteine amino acids within a protein. These bonds help proteins fold correctly and maintain their shape, which is crucial for their function. They can also be used to modify proteins for specific purposes.

---

sequence variants

Variations in the DNA sequence that can alter protein structure and function.

Sequence variants are changes in the DNA code that make up a gene. These changes can lead to different versions of a protein being produced. Some variants have no effect, while others can change how a protein works or even cause disease.

---

molecular simulation methods

Computer-based techniques used to model and predict the behavior of molecules.

Molecular simulation methods use computers to simulate how atoms and molecules interact. This allows scientists to study the structure and function of biological systems at a detailed level. Simulations can be used to design new drugs, understand how diseases work, and develop new materials.

---

protein binder scaffolds

Structural frameworks for creating proteins that bind to specific targets.

Protein binder scaffolds are the basic building blocks for designing drugs. They are designed to hold together other molecules that can interact with a specific target, such as a disease-causing protein. This allows scientists to create highly specific and effective therapies.

---

affibody

A genetically engineered protein that binds to a specific target with high affinity.

Affibody is a type of antibody-like protein designed to bind tightly to specific targets. They are smaller and more stable than traditional antibodies, making them suitable for various therapeutic applications.

---

cancer therapeutics

Medical treatments used to combat cancer.

Cancer therapeutics are medications or therapies designed to treat cancer. They work by killing cancer cells, slowing their growth, or relieving symptoms associated with the disease. There are many different types of cancer therapeutics, including chemotherapy, radiation therapy, and targeted therapy.